Saraav Iti, Huang Wanyi, Jung Jisun, Xu Rui, Fu Yong, McDonald Keely, Schriefer Lawrence A, Rodgers Rachel, Baldridge Megan T, Newberry Rodney D, Hsieh Chyi-Song, Sibley L David
Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
Department of Internal Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, USA.
Gut Microbes. 2025 Dec;17(1):2551115. doi: 10.1080/19490976.2025.2551115. Epub 2025 Aug 28.
To examine the effect of early-life infection with on the development of oral tolerance, we developed a low-dose infection model in neonatal mice. infection in neonatal mice results in immunopathology in the colon. IL-1β released during infection blocked the formation of colonic goblet cell associated antigen passages, which normally serve as a conduit for antigen uptake and development of peripheral regulatory T cells (pTregs), responsible for long-term oral tolerance. Following infection with , adoptively transferred OT-II cells, which respond to ovalbumin (ova, a model food antigen), underwent expansion of T1-like Tregs in the colon while the frequency of Foxp3Rorγt cells in mesenteric lymph nodes decreased. The altered pTreg profile was accompanied by a strong T1 immune response and robust IgG2c antibody responses to orally administered ova. Our findings suggest that intestinal inflammation and altered pTreg cells lead to loss of oral tolerance during early life infection with .
为了研究生命早期感染[病原体名称未给出]对口服耐受发展的影响,我们在新生小鼠中建立了低剂量感染模型。新生小鼠感染[病原体名称未给出]会导致结肠免疫病理学变化。在[病原体名称未给出]感染期间释放的白细胞介素-1β阻断了结肠杯状细胞相关抗原通道的形成,这些通道通常作为抗原摄取和外周调节性T细胞(pTregs)发育的管道,而外周调节性T细胞负责长期口服耐受。在用[病原体名称未给出]感染后,过继转移的对卵清蛋白(ova,一种模型食物抗原)有反应的OT-II细胞在结肠中经历了T1样调节性T细胞的扩增,而肠系膜淋巴结中Foxp3Rorγt细胞的频率降低。pTreg细胞谱的改变伴随着强烈的T1免疫反应和对口服卵清蛋白的强大IgG2c抗体反应。我们的研究结果表明,肠道炎症和pTreg细胞的改变导致生命早期感染[病原体名称未给出]期间口服耐受的丧失。
Gut Microbes. 2025-12
J Biomed Mater Res A. 2025-7
Microbiol Spectr. 2025-6-25
Drug Deliv Transl Res. 2024-10
Parasite Immunol. 2025-6
Microorganisms. 2024-7-12
Immunol Rev. 2024-9
Proc Natl Acad Sci U S A. 2024-3-26
Immunity. 2023-7-11